logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Hospital Center Universitaire Hospital Saint Eloi

+33467336733
crth@chu-montpellier.fr
Source: Site record.
http://www.chu-montpellier.fr

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Hôpital Saint-Eloi is a prominent public university hospital operating as a key specialized site under the Centre Hospitalier Universitaire (CHU) de Montpellier network. Located at 80 Avenue Augustin Fliche, 34090 Montpellier, France, this historic facility blends long-standing medical traditions with advanced 21st-century medicine. It serves as the region's primary center for digestive system disorders and hematological specialties, boasting world-class expertise in liver transplantations, abdominal oncology, and clinical research. The hospital features a capacity of roughly 525 beds across medicine, surgery, and psychiatry departments.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. General hospital
Source: Human-provided. Hospital
Source: Trial-derived.
97Total Trials
Source: Trial-derived.
23Recruiting Trials
Source: Trial-derived.
44Active Trials
Source: Trial-derived.
39Completed Trials
Source: Trial-derived.
134Unique Conditions
Source: Trial-derived.
78Unique Sponsors

Conditions

Source: Trial-derived. Ulcerative Colitis (7)Source: Trial-derived. Crohn Disease (4)Source: Trial-derived. Acute Myeloid Leukemia (3)Source: Trial-derived. Intensive Care Unit (3)Source: Trial-derived. Hepatocellular Carcinoma (2)Source: Trial-derived. Hodgkin Lymphoma (2)Source: Trial-derived. Invasive Mechanical Ventilation (2)Source: Trial-derived. Lymphedema Lower Extremity (2)

Sponsors

Source: Trial-derived. University Hospital, Montpellier (9)Source: Trial-derived. The Lymphoma Academic Research Organisation (8)Source: Trial-derived. Assistance Publique - Hôpitaux de Paris (5)Source: Trial-derived. Hoffmann-La Roche (5)Source: Trial-derived. Hospices Civils de Lyon (5)Source: Trial-derived. Centre Hospitalier Universitaire de Nīmes (4)Source: Trial-derived. Janssen Research & Development, LLC (4)Source: Trial-derived. Merck Sharp & Dohme LLC (4)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. PET-CT
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. MRI
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. Spirometry

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Biobanking
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Liver biopsy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Peripheral angiography and endovascular intervention

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Continuous pulse oximetry monitoring
Source: AI-inferred. Electronic clinical outcome assessment (eCOA/ePRO) platform
Source: AI-inferred. Electronic patient-reported outcome (eDiary) system
Source: AI-inferred. FLT3-ITD mutation and minimal residual disease testing
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Left ventricular ejection fraction measurement
Source: AI-inferred. Liver transplantation programme
Source: AI-inferred. Lymphocyte immunophenotyping